Home » Shop » Research Peptides » Tesamorelin

Tesamorelin

Research Applications

Designed for precision research, these peptides support a wide range of experimental protocols. Ideal for laboratory studies requiring consistent, reproducible compound delivery.

Safety & Compliance

All products are intended for research use only. Follow standard lab safety guidelines, including proper protective equipment and waste disposal protocols.

Tesamorelin is a synthetic 44-amino acid peptide analog of growth hormone-releasing hormone (GHRH) with a trans-3-hexenoyl modification at the N-terminus for increased stability and potency.

It stimulates the pituitary gland to release endogenous growth hormone (GH) in a pulsatile manner. In research models, Tesamorelin is studied for its ability to reduce visceral adipose tissue (abdominal fat), improve body composition, and support metabolic health while maintaining a more physiological GH release profile compared to direct GH administration.

Key Research Areas:

  • Growth hormone stimulation and pulsatile release
  • Visceral fat reduction and body composition
  • Metabolic regulation and lipid metabolism
  • Anti-aging and longevity models
  • HIV-associated lipodystrophy and endocrine studies

📚Sources & References

Journal of Clinical Endocrinology & Metabolism

Effects of tesamorlin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials

2010•PMID: 20554713

Falutz J, et al.

Lancet HIV

 

Effects of tesamorlin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial

2019•PMID: 31611038

Stanley TL, et al.

Archives of Neurology

 

Effects of growth hormone-releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults

2012•PMID: 22869065

Baker LD, et al.

Journal of Clinical Endocrinology & Metabolism

The Growth Hormone Releasing Hormone Analogue, Tesamorlin, Decreases Muscle Fat and Increases Muscle Area in Adults with HIV

2019•PMID: 31050749

Adrian S, et al.

JCI Insight

 

Effects of tesamorlin on hepatic transcriptomic signatures in HIV-associated NAFLD

2020•PMID: 32780726

Fourman LT, et al.

FDA

 

EGRIFTA (tesamorlin) Prescribing Information

2025

Theratechnologies Inc.

⚠️Important Research Notice

Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.

All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.

By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.

WeightN/A
DimensionsN/A
Size10mg, 5mg

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.